<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39382736</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-501X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Molecular diversity</Title><ISOAbbreviation>Mol Divers</ISOAbbreviation></Journal><ArticleTitle>Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11030-024-10993-8</ELocationID><Abstract><AbstractText>The emergence of new SARS-CoV-2 variants with a higher contagious capability and faster transmissible speed has imposed an incessant menace on global health and the economy. The SARS-CoV-2 infection might reoccur and last much longer than expected. Thence, there is a high possibility that COVID-19 can cause long-term health problems. This condition needs to be investigated thoroughly, especially the post-COVID-19 complications. Respiratory tract disorders are common and typical complications after recovery. Until now, there has been a lack of data on specialized therapeutic medicine for post-COVID-19 complications. The clinical efficacy of NRICM101 has been demonstrated in hospitalized COVID-19 patients. This herbal medicine may also be a promising therapy for post-COVID-19 complications, thanks to its phytochemical constituents. The potential pharmacological mechanisms of NRICM101 in treating post-COVID-19 respiratory complications were investigated using network pharmacology combined with molecular docking, and the results revealed that NRICM101 may exert a beneficial effect through the three primary pathways: PI3K/AKT, HIF-1, and TNF signaling pathways. Flavonoids (especially quercetin) have a predominant role and synergize with other active compounds to produce therapeutic effectiveness. Most of the main active compounds exist in three chief herbal ingredients, including Liquorice root (Glycyrrhiza glabra), Scutellaria root (Scutellaria baicalensis), and Mulberry leaf (Morus alba). To our knowledge, this is the first study of the NRICM101 effect on post-COVID-19 respiratory complications. Our findings may provide a better understanding of the potential mechanisms of NRICM101 in treating SARS-CoV-2 infection and regulating the immunoinflammatory response to improve post-COVID-19 respiratory complications.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huynh</LastName><ForeName>Dung Tam Nguyen</ForeName><Initials>DTN</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Can Tho City, 94117, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Hien Thi</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Safety, Faculty of Public Health, Can Tho University of Medicine and Pharmacy, Can Tho City, 94117, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chien-Ming</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan. cmhsieh@tmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Divers</MedlineTA><NlmUniqueID>9516534</NlmUniqueID><ISSNLinking>1381-1991</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 complications</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">NRICM101</Keyword><Keyword MajorTopicYN="N">Network pharmacology</Keyword><Keyword MajorTopicYN="N">Respiratory tract disease</Keyword><Keyword MajorTopicYN="N">Taiwan Chingguan Yihau</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382736</ArticleId><ArticleId IdType="doi">10.1007/s11030-024-10993-8</ArticleId><ArticleId IdType="pii">10.1007/s11030-024-10993-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pubmed">32592501</ArticleId><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T (2022) The delta and omicron variants of SARS-CoV-2: what we know so far. Vaccines 10(11):1926</Citation><ArticleIdList><ArticleId IdType="pubmed">36423021</ArticleId><ArticleId IdType="pmc">9698608</ArticleId><ArticleId IdType="doi">10.3390/vaccines10111926</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P (2021) NICE guideline on long COVID. Lancet Respir Med 9(2):129</Citation><ArticleIdList><ArticleId IdType="pubmed">33453162</ArticleId><ArticleId IdType="pmc">7832375</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardel&#x10d;&#xed;kov&#xe1; A, Miro&#x161;&#x161;ay A, &#x160;olt&#xfd;s J, Moj&#x17e;i&#x161; J (2022) Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy. Phytother Res 36(5):2042&#x2013;2060</Citation><ArticleIdList><ArticleId IdType="pubmed">35302260</ArticleId><ArticleId IdType="pmc">9111001</ArticleId><ArticleId IdType="doi">10.1002/ptr.7436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The economic cost of long COVID: an update: Harvard University 2022. https://scholar.harvard.edu/cutler/news/long-covid .</Citation></Reference><Reference><Citation>Alhiyari MA, Ata F, Alghizzawi MI, Bilal AB, Abdulhadi AS, Yousaf Z (2021) Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases 23:e01041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e01041</ArticleId></ArticleIdList></Reference><Reference><Citation>Maranatha D, Hasan H, Bakhtiar A, Widyoningroem A, Aryati (2022) Association of TNF-&#x3b1;, TGF-&#x3b2;1, amphiregulin, IL-2, and EGFR with pulmonary fibrosis in COVID-19. J Infect Public Health 15(10):1072&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">36088825</ArticleId><ArticleId IdType="pmc">9398556</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2022.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigh S, Rehman MU, Khan A, Patil BR, Makeen HA, Rasool S et al (2022) Therapeutic role of flavonoids in lung inflammatory disorders. Phytomed Plus 2(1):100221</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phyplu.2022.100221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini SA, Zahedipour F, Sathyapalan T, Jamialahmadi T, Sahebkar A (2021) Pulmonary fibrosis: therapeutic and mechanistic insights into the role of phytochemicals. BioFactors 47(3):250&#x2013;269</Citation><ArticleIdList><ArticleId IdType="pubmed">33548106</ArticleId><ArticleId IdType="doi">10.1002/biof.1713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K-C, Huang Y-C, Liaw C-C, Tsai C-I, Chiou C-T, Lin C-J et al (2021) A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study. Biomed Pharmacother 133:111037</Citation><ArticleIdList><ArticleId IdType="pubmed">33249281</ArticleId><ArticleId IdType="doi">10.1016/j.biopha.2020.111037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S et al (2022) The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 3(6):100663</Citation><ArticleIdList><ArticleId IdType="pubmed">35732153</ArticleId><ArticleId IdType="pmc">9214726</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J et al (2021) HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 49(D1):D1197&#x2013;D1206</Citation><ArticleIdList><ArticleId IdType="pubmed">33264402</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa1063</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717</Citation><ArticleIdList><ArticleId IdType="pubmed">28256516</ArticleId><ArticleId IdType="pmc">5335600</ArticleId><ArticleId IdType="doi">10.1038/srep42717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al (2020) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49(D1):D1388&#x2013;D1395</Citation><ArticleIdList><ArticleId IdType="pmc">7778930</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa971</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC et al (2020) Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res 49(D1):D1138&#x2013;D1143</Citation><ArticleIdList><ArticleId IdType="pmc">7779006</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa891</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S et al (2020) The STRING database in 2021: customizable protein&#x2013;protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 49(D1):D605&#x2013;D612</Citation><ArticleIdList><ArticleId IdType="pmc">7779004</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498&#x2013;2504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId><ArticleId IdType="pmc">403769</ArticleId><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge SX, Jung D, Yao R (2019) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36(8):2628&#x2013;2629</Citation><ArticleIdList><ArticleId IdType="pmc">7178415</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btz931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T et al (2017) GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database. https://doi.org/10.1093/database/bax028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/bax028</ArticleId><ArticleId IdType="pubmed">28605766</ArticleId><ArticleId IdType="pmc">5467550</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39:W270-7. https://doi.org/10.1093/nar/gkr366</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr366</ArticleId><ArticleId IdType="pubmed">21624888</ArticleId><ArticleId IdType="pmc">3125772</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosdidier A, Zoete V, Michielin O (2011) Fast docking using the CHARMM force field with EADock DSS. J Comput Chem 32(10):2149&#x2013;2159</Citation><ArticleIdList><ArticleId IdType="pubmed">21541955</ArticleId><ArticleId IdType="doi">10.1002/jcc.21797</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al (2000) The protein data bank. Nucleic Acids Res 28(1):235&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pubmed">10592235</ArticleId><ArticleId IdType="pmc">102472</ArticleId><ArticleId IdType="doi">10.1093/nar/28.1.235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanner MF, Olson AJ, Spehner JC (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38(3):305&#x2013;320</Citation><ArticleIdList><ArticleId IdType="pubmed">8906967</ArticleId><ArticleId IdType="doi">10.1002/(SICI)1097-0282(199603)38:3&lt;305::AID-BIP4&gt;3.0.CO;2-Y</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera&#x2014;a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605&#x2013;1612</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Chen X, Ni W, Zhou D, Chai S, Ye W et al (2021) The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study. RSC Adv 11(20):11821&#x2013;11843</Citation><ArticleIdList><ArticleId IdType="pubmed">35423770</ArticleId><ArticleId IdType="pmc">8696653</ArticleId><ArticleId IdType="doi">10.1039/D0RA07035A</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C-H, Hwang K-C, Chao C-L, Chang SGN, Ho M-S, Lin J-G et al (2008) An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study. Evid-Based Complement Altern Med 5:273504</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecam/nem035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C-H, Hwang K-C, Chao C-L, Chang SG, Ker C-C, Chien L-C et al (2006) The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients. Am J Chin Med 34(06):927&#x2013;935</Citation><ArticleIdList><ArticleId IdType="pubmed">17163582</ArticleId><ArticleId IdType="doi">10.1142/S0192415X06004405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lem FF, Opook F, Lee DJH, Chee FT, Lawson FP, Chin SN (2021) Molecular mechanism of action of repurposed drugs and traditional chinese medicine used for the treatment of patients infected with COVID-19: a systematic scoping review. Front Pharmacol 11:58533</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.585331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L, Lee HW, Choi JY, Zhang J, Lee MS (2020) Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res 9(2):100407</Citation><ArticleIdList><ArticleId IdType="pubmed">32289016</ArticleId><ArticleId IdType="pmc">7104236</ArticleId><ArticleId IdType="doi">10.1016/j.imr.2020.100407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-b, Wang Z-x, Jing J, Zhao P, Dong J-h, Zhou Y-f et al (2020) Exploring an integrative therapy for treating COVID-19: a randomized controlled trial. Chin J Integr Med 26(9):648&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">32676976</ArticleId><ArticleId IdType="pmc">7364292</ArticleId><ArticleId IdType="doi">10.1007/s11655-020-3426-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S et al (2022) Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 98:153930</Citation><ArticleIdList><ArticleId IdType="pubmed">35114450</ArticleId><ArticleId IdType="pmc">8730822</ArticleId><ArticleId IdType="doi">10.1016/j.phymed.2022.153930</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A (2021) Post-COVID syndrome: an insight on its pathogenesis. Vaccines 9(5):497</Citation><ArticleIdList><ArticleId IdType="pubmed">34066007</ArticleId><ArticleId IdType="pmc">8151752</ArticleId><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M (2022) Pathological sequelae of long-haul COVID. Nat Immunol 23(2):194&#x2013;202</Citation><ArticleIdList><ArticleId IdType="pubmed">35105985</ArticleId><ArticleId IdType="pmc">9127978</ArticleId><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z-H, Wang B, Ma Q, Wang L, Lin Y-X, Yan H-F et al (2021) Potential mechanisms of action of Chinese patent medicines for COVID-19: a review. Front Pharmcol. https://doi.org/10.3389/fphar.2021.668407</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.668407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X, Jin D, Jiang L, Zhang Y, Zhang Y, An X et al (2022) Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review. Chin Med 17(1):30</Citation><ArticleIdList><ArticleId IdType="pubmed">35227280</ArticleId><ArticleId IdType="pmc">8883015</ArticleId><ArticleId IdType="doi">10.1186/s13020-022-00587-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S, Xue T, Wang B, Guo H, Liu Q (2022) Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19. Front Pharmacol 13:926901</Citation><ArticleIdList><ArticleId IdType="pubmed">35991891</ArticleId><ArticleId IdType="pmc">9387999</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.926901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HT, Do VM, Phan TT, Nguyen Huynh DT (2023) The potential of ameliorating COVID-19 and sequelae from Andrographis paniculata via bioinformatics. Bioinform Biol Insights 17:11779322221149622</Citation><ArticleIdList><ArticleId IdType="pubmed">36654765</ArticleId><ArticleId IdType="pmc">9841859</ArticleId><ArticleId IdType="doi">10.1177/11779322221149622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffal SM, Abbas MA (2021) TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem Biol Interact 345:109567</Citation><ArticleIdList><ArticleId IdType="pubmed">34166652</ArticleId><ArticleId IdType="pmc">8217345</ArticleId><ArticleId IdType="doi">10.1016/j.cbi.2021.109567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternesten-Hass&#xe9;us E, Johansson E-L, Millqvist E (2015) Cough reduction using capsaicin. Respir Med 109(1):27&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">25468411</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2014.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Hao Q, Mu Y, Timani KA, Ye L, Zhu Y et al (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int J Biochem Cell Biol 38(8):1417&#x2013;1428</Citation><ArticleIdList><ArticleId IdType="pubmed">16546436</ArticleId><ArticleId IdType="pmc">7108415</ArticleId><ArticleId IdType="doi">10.1016/j.biocel.2006.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight D, Mutsaers SE, Pr&#xea;le CM (2011) STAT3 in tissue fibrosis: is there a role in the lung? Pulm Pharmacol Ther 24(2):193&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">20951825</ArticleId><ArticleId IdType="doi">10.1016/j.pupt.2010.10.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N, Dantzer R, Khandaker GM (2021) Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 131:105295</Citation><ArticleIdList><ArticleId IdType="pubmed">34119855</ArticleId><ArticleId IdType="pmc">8172271</ArticleId><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou N, Harokopos V, Zalevsky J, Valavanis C, Kotanidou A, Szymkowski DE et al (2006) Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS ONE 1(1):e108</Citation><ArticleIdList><ArticleId IdType="pubmed">17205112</ArticleId><ArticleId IdType="pmc">1762410</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0000108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-M, Park JW, Cho W-K, Zhou Y, Han B, Yoon PO et al (2014) Modifiers of TGF-b1 effector function as novel therapeutic targets of pulmonary fibrosis. Korean J Intern Med 29(3):281&#x2013;290</Citation><ArticleIdList><ArticleId IdType="pubmed">24851060</ArticleId><ArticleId IdType="pmc">4028515</ArticleId><ArticleId IdType="doi">10.3904/kjim.2014.29.3.281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M-X, Song X, Ma X-Q, Hao C-X, Huang J-J, Yang W-H (2021) Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining. Ann Palliat Med 10(4):3960&#x2013;3975</Citation><ArticleIdList><ArticleId IdType="pubmed">33832291</ArticleId><ArticleId IdType="doi">10.21037/apm-20-1384</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao B, Wu Y, Li X, Xu Z, Duan W, Hu Y et al (2020) A Network pharmacology approach to explore the potential mechanisms of Yifei Sanjie formula in treating pulmonary fibrosis. Evid-Based Complement Altern Med 2020:8887017</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8887017</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Lv F, Huang Y, Xiao K (2021) Follow-up study of the chest CT characteristics of COVID-19 survivors seven months after recovery. Front Med 8:636298</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.636298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X-Y, Yan B-X, Man X-Y (2020) TNF&#x3b1; inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis. Ther Adv Respir Dis 14:1753466620926800</Citation><ArticleIdList><ArticleId IdType="pubmed">32436460</ArticleId><ArticleId IdType="pmc">7243041</ArticleId><ArticleId IdType="doi">10.1177/1753466620926800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablamunits V, Lepsy C (2022) Blocking TNF signaling may save lives in COVID-19 infection. Mol Biol Rep 49(3):2303&#x2013;2309</Citation><ArticleIdList><ArticleId IdType="pubmed">35076845</ArticleId><ArticleId IdType="pmc">8787182</ArticleId><ArticleId IdType="doi">10.1007/s11033-022-07166-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A, Johnson TP (2022) Mechanisms of viral persistence in the brain and therapeutic approaches. FEBS J 289(8):2145&#x2013;2161</Citation><ArticleIdList><ArticleId IdType="pubmed">33844441</ArticleId><ArticleId IdType="doi">10.1111/febs.15871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmat N, Asadzadeh Z, Ahangar NK, Alemohammad H, Najafzadeh B, Derakhshani A et al (2021) The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Adv Virol 166(3):675&#x2013;696</Citation></Reference><Reference><Citation>Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L (2020) Hypoxia, HIF-1&#x3b1;, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin 41(12):1539&#x2013;1546</Citation><ArticleIdList><ArticleId IdType="pubmed">33110240</ArticleId><ArticleId IdType="doi">10.1038/s41401-020-00554-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilaki N, Frakolaki E (2017) Virus&#x2013;host interactions under hypoxia. Microbes Infect 19(3):193&#x2013;203</Citation><ArticleIdList><ArticleId IdType="pubmed">27771294</ArticleId><ArticleId IdType="doi">10.1016/j.micinf.2016.10.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani M, Dokaneheifard S, Mansouri K (2020) Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm 17(1):33</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-020-00263-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian M, Liu W, Li X, Zhao P, Shereen MA, Zhu C et al (2021) HIF-1&#x3b1; promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6(1):308</Citation><ArticleIdList><ArticleId IdType="pubmed">34408131</ArticleId><ArticleId IdType="pmc">8371950</ArticleId><ArticleId IdType="doi">10.1038/s41392-021-00726-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y-C, Tseng L-W, Huang Y-C, Yang C-W, Chen Y-C, Chen H-Y (2022) The potential complementary role of using Chinese herbal medicine with western medicine in treating COVID-19 patients: pharmacology network analysis. Pharmaceuticals 15(7):794</Citation><ArticleIdList><ArticleId IdType="pubmed">35890093</ArticleId><ArticleId IdType="pmc">9323801</ArticleId><ArticleId IdType="doi">10.3390/ph15070794</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F et al (2022) Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 124(5):151908</Citation><ArticleIdList><ArticleId IdType="pubmed">35662001</ArticleId><ArticleId IdType="pmc">9130726</ArticleId><ArticleId IdType="doi">10.1016/j.acthis.2022.151908</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>